# Glucose metabolic dysregulation of diabetes and Its role in atrial fibrillation pathogenesis

**Authors:** Yuqi Chen, Min Xu, Ke Wei, Nan Ma

PMC · DOI: 10.3389/fcvm.2025.1711069 · Frontiers in Cardiovascular Medicine · 2026-02-19

## TL;DR

This paper explores how diabetes-related glucose metabolism issues contribute to the development of atrial fibrillation, a common heart rhythm disorder.

## Contribution

The paper reviews novel mechanisms linking glucose dysregulation in diabetes to the onset of atrial fibrillation.

## Key findings

- Diabetes increases the risk of atrial fibrillation beyond just high blood sugar levels.
- Blood glucose fluctuations and metabolic disturbances play a role in atrial fibrillation pathogenesis.
- Abnormal glucose metabolism pathways are potentially involved in causing atrial fibrillation in diabetic patients.

## Abstract

Atrial fibrillation (AF) is the most prevalent persistent arrhythmia in clinical practice, with a complex pathogenesis that remains incompletely understood. Emerging evidence underscores a strong association between diabetes and the occurrence of AF, highlighting a significantly elevated risk among diabetic patients. This increased susceptibility is not solely attributable to chronic hyperglycemia but is also shaped by blood glucose fluctuations and dysregulated glucose metabolism. In this review, we summarize the mechanisms by which hyperglycemia and blood glycemic variability contribute to the onset of AF, and the potential involvement of abnormal glucose metabolism pathways and metabolic disturbances induced by diabetes in the pathogenesis of AF.

## Linked entities

- **Diseases:** diabetes (MONDO:0005015), atrial fibrillation (MONDO:0004981)

## Full-text entities

- **Genes:** Cdkn2a (cyclin dependent kinase inhibitor 2A) [NCBI Gene 12578] {aka ARF-INK4a, Arf, INK4a-ARF, Ink4a/Arf, MTS1, Pctr1}, AKR1B1 (aldo-keto reductase family 1 member B) [NCBI Gene 231] {aka ADR, ALDR1, ALR2, AR}, TKT (transketolase) [NCBI Gene 7086] {aka HEL-S-48, HEL107, SDDHD, TK, TKT1}, Stam2 (signal transducing adaptor molecule (SH3 domain and ITAM motif) 2) [NCBI Gene 56324] {aka 1200004O12Rik, 5730456G07Rik, Hbp}, TXNIP (thioredoxin interacting protein) [NCBI Gene 10628] {aka ARRDC6, EST01027, HHCPA78, THIF, VDUP1}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, Rb1 (RB transcriptional corepressor 1) [NCBI Gene 19645] {aka Rb, Rb-1, p110-RB1, pRb, pp105}, Fdxr (ferredoxin reductase) [NCBI Gene 14149] {aka AR}, SORD (sorbitol dehydrogenase) [NCBI Gene 6652] {aka HEL-S-95n, HMNR8, RDH, SDH, SORD1, SORDD}, ENO3 (enolase 3) [NCBI Gene 2027] {aka GSD13, MSE}, Ccn2 (cellular communication network factor 2) [NCBI Gene 64032] {aka CTGRP, Ctgf}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, HK1 (hexokinase 1) [NCBI Gene 3098] {aka CNSHA5, HK, HK1-ta, HK1-tb, HK1-tc, HKD}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, GLP1R (glucagon like peptide 1 receptor) [NCBI Gene 2740] {aka GLP-1, GLP-1-R, GLP-1R}, Pim1 (Pim1, proto-oncogene, serine/threonine kinase) [NCBI Gene 18712] {aka Pim-1}, Ager (advanced glycosylation end product-specific receptor) [NCBI Gene 81722] {aka RAGE}, AGER (advanced glycosylation end-product specific receptor) [NCBI Gene 177] {aka RAGE, SCARJ1, sRAGE}, Prkaa2 (protein kinase AMP-activated catalytic subunit alpha 2) [NCBI Gene 78975] {aka Ampk, Ampka2}, Gja5 (gap junction protein, alpha 5) [NCBI Gene 50563] {aka Cx40, Cxni}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, SLC2A1 (solute carrier family 2 member 1) [NCBI Gene 6513] {aka CSE, DYT17, DYT18, DYT9, EIG12, GLUT}, Gja1 (gap junction protein, alpha 1) [NCBI Gene 24392] {aka Cx43, Cxnk1}, OGT (O-linked N-acetylglucosamine (GlcNAc) transferase) [NCBI Gene 8473] {aka HINCUT-1, HRNT1, MRX106, O-GLCNAC, OGT1, XLID106}, Mfn2 (mitofusin 2) [NCBI Gene 170731] {aka D630023P19Rik, Fzo}, GPI (glucose-6-phosphate isomerase) [NCBI Gene 2821] {aka AMF, CNSHA4, GNPI, NLK, PGI, PHI}, Ryr2 (ryanodine receptor 2, cardiac) [NCBI Gene 20191] {aka 9330127I20Rik, RYR-2}, G6PD (glucose-6-phosphate dehydrogenase) [NCBI Gene 2539] {aka CNSHA1, G6PD1}, Camk2b (calcium/calmodulin-dependent protein kinase II, beta) [NCBI Gene 12323] {aka CaMKII}, SLC5A2 (solute carrier family 5 member 2) [NCBI Gene 6524] {aka SGLT2}, RYR2 (ryanodine receptor 2) [NCBI Gene 6262] {aka ARVC2, ARVD2, RYR-2, RyR, VACRDS, VTSIP}, MFN2 (mitofusin 2) [NCBI Gene 9927] {aka CMT2A, CMT2A2, CMT2A2A, CMT2A2B, CPRP1, HMSN6A}, Ager (advanced glycosylation end product-specific receptor) [NCBI Gene 11596] {aka RAGE}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, Bcl2 (B cell leukemia/lymphoma 2) [NCBI Gene 12043] {aka Bcl-2, C430015F12Rik, D630044D05Rik, D830018M01Rik}, PRRT2 (proline rich transmembrane protein 2) [NCBI Gene 112476] {aka BFIC2, BFIS2, DSPB3, DYT10, EKD1, FICCA}, Renbp (renin binding protein) [NCBI Gene 19703] {aka Age, Rnbp}, Pdk4 (pyruvate dehydrogenase kinase, isoenzyme 4) [NCBI Gene 27273], DPP4 (dipeptidyl peptidase 4) [NCBI Gene 1803] {aka ADABP, ADCP2, CD26, DPPIV, TP103}, GFPT1 (glutamine--fructose-6-phosphate transaminase 1) [NCBI Gene 2673] {aka CMS12, CMSTA1, GFA, GFAT, GFAT 1, GFAT1}, PDK4 (pyruvate dehydrogenase kinase 4) [NCBI Gene 5166], VCAM1 (vascular cell adhesion molecule 1) [NCBI Gene 7412] {aka CD106, INCAM-100}
- **Diseases:** Energy deficiency (MESH:D011502), stroke (MESH:D020521), pre (MESH:D058246), arrhythmia (MESH:D001145), CML (MESH:D020167), tachycardia (MESH:D013610), bradycardia (MESH:D001919), hypoxia (MESH:D000860), ischemia (MESH:D007511), metabolic (MESH:D008659), mitochondrial dysfunction (MESH:D028361), atrial fibrosis (MESH:D005355), Hyperglycemia (MESH:D006943), Disease (MESH:D004194), atrial inflammation (MESH:D007249), Glucose metabolic dysregulation (MESH:D044882), GV (MESH:C537362), Metabolic disruptions (MESH:D019958), NAD+ deficiency (MESH:D016111), Diabetes (MESH:D003920), tumor (MESH:D009369), dementia (MESH:D003704), cardiac damage (MESH:D006331), atrial myopathy (MESH:D009135), heart failure (MESH:D006333), infarct (MESH:D007238), type 1 and type 2 diabetic (MESH:D003924), ion channel dysfunction (MESH:D020513), autonomic neuropathy (MESH:D009422), glucose (MESH:D018149), atherosclerosis (MESH:D050197), diabetic cardiomyopathy (MESH:D058065), cardiomyocyte death (MESH:D003643), reperfusion injury (MESH:D015427), Insulin resistance (MESH:D007333), thickening (MESH:D013585), AF (MESH:D001281), myocardial ischemia (MESH:D017202), myocardial infarction (MESH:D009203), interstitial (MESH:D065167), diabetic neuropathy (MESH:D003929), cardiovascular death (MESH:D002318)
- **Chemicals:** glycogen (MESH:D006003), metformin (MESH:D008687), Sorbitol (MESH:D013012), epalrestat (MESH:C038131), AGEs (MESH:D017127), Blood glucose (MESH:D001786), UDP- (MESH:D014530), CML (MESH:C048496), resveratrol (MESH:D000077185), pyruvate (MESH:D019289), TCA (MESH:D014233), GlcN6P (MESH:C001293), pentose phosphate (MESH:D010428), Glc6P (MESH:D019298), Lactate (MESH:D019344), Polyol (MESH:C024617), pentosidine (MESH:C062187), CEL (MESH:C000612723), lipid (MESH:D008055), GSH (MESH:D005978), benfotiamine (MESH:C013835), Fructose (MESH:D005632), ATP (MESH:D000255), hexosamine (MESH:D006595), calcium (MESH:D002118), ROS (MESH:D017382), Glucose (MESH:D005947), 3-deoxyglucosone (MESH:C016350), NAD+ (MESH:D009243), sodium (MESH:D012964), fructose-3-phosphate (MESH:C062519), UDP-N-acetylglucosamine (MESH:D014537), GV (-), phosphatidylserine (MESH:D010718), fatty acid (MESH:D005227), ribose phosphate (MESH:C031626), NADPH (MESH:D009249)
- **Species:** Canis lupus familiaris (dog, subspecies) [taxon 9615], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Cell lines:** HL-1 — Mus musculus (Mouse), Transformed cell line (CVCL_0303)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12960591/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12960591/full.md

## References

119 references — full list in the complete paper: https://tomesphere.com/paper/PMC12960591/full.md

---
Source: https://tomesphere.com/paper/PMC12960591